Glioma samples from the Cancer Genome Atlas and Human Protein Atls databases were extracted to detect the mRNA and protein expression levels of ADRB1 and ADRB2 and analyze the correlation between expression and survival of glioma patients. The gene discussed is ADRB2; the disease is central nervous system cancer.